Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- NFLX +13.6%, AUB +9.9%, LNN +6.6%, LVS +5.9% (also increases buyback auth to $2 bln), SAP +5%, T +5%, COLB +4.3%, WBS +4.2%, TSM +3.7%, LBRT +2.9%, FR +1.8%, AAL +1.8%, TFC +1.6%, KEY +1.6%, SNA +1.5%, FNB +1.1%, REXR +1%, FITB +0.8%
Other news:
- CAAP +3% (reports Sept traffic)
- ACHR +2.4% (STLA discloses 15.1% stake in ACHR)
- PB +2% (increases dividend)
- CYTK +2% (will provide an update on the company's cardiac myosin inhibitor programs and plans to build a specialty cardiology franchise at its virtual Investor and Analyst Day "New Horizons in Hypercontractility")
- ALSN +1.9% (X1100-5A3 cross-drive propulsion solution selected for Australian armored vehicle project)
- ROKU +1.9% (in sympathy with NFLX earnings)
- XEL +1.1% (receives $100 mln Dept of Energy grant)
- MTX +1% (increases dividend)
- MRO +1% (DVN mulling M&A activity with MRO and CrownRock according to Bloomberg)
- PARA +0.9% (in sympathy with NFLX earnings)
Analyst comments:
- RCM +4.1% (upgraded to Buy from Hold at Truist)
- APTV +2.8% (upgraded to Overweight from Neutral at JP Morgan)
- BBY +2.5% (upgraded to Buy from Neutral at Goldman)
- KTB +2.2% (upgraded to Buy from Neutral at Goldman)
- CRWD +2.1% (upgraded to Buy from Hold at Jefferies)
- ZS +2% (upgraded to Buy from Hold at Jefferies)
- FSLR +1.9% (upgraded to Overweight from Neutral at JP Morgan)